The niaid DIR FY26-27 operational task order
Active Awarded Last action
- Contract number
- 75N91025F00013
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $17,766,274
Award facts
- Contract value 99% obligated
- $17,912,355.00 Current and potential, with all options
- Completion date 57% complete
- Current and potential, with all options
- Funding agency
- National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $7,604,104 | |
| Other Administrative Action | $91,581 | |
| Other Administrative Action | $1,320,586 | |
| Funding Only Action | $7,450,000 | |
| Original award | $1,300,003 |
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to Leidos Biomedical Research Inc. on August 31, 2025, with a ceiling value of $17.9 million under the NIAID master indefinite delivery contract HHSN261201500003I. The order covers operational support for infectious disease research and facility operations, with performance at Frederick, MD and ultimate completion by August 30, 2027.
Leidos Biomedical Research operates the Frederick National Laboratory for Cancer Research on behalf of the National Institutes of Health as an FFRDC contractor. This is a cost-plus-fixed-fee delivery order issued without set-aside. Service Contract Inventory reporting for FY2025 reflects $657 thousand invoiced against this order with 0.4 FTEs, self-performed by the prime contractor with no subcontractors reported. The vendor maintains a stable workforce of approximately 1,830 FTEs across its NIH portfolio, with government-paid hourly rates ranging from $70.79 to $1,379.73 per hour depending on labor classification.
Quick answers
Who was awarded contract 75N91025F00013?
75N91025F00013 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on August 31, 2025.
How much is contract 75N91025F00013 worth?
The government has obligated $17,766,274 on 75N91025F00013. Its current value, with exercised options, is $17,912,355.
Which agency awarded contract 75N91025F00013?
National Cancer Institute (National Institutes of Health) awarded 75N91025F00013, with funding from National Institute of Allergy and Infectious Diseases (National Institutes of Health).
Is contract 75N91025F00013 an order under another contract?
Yes. 75N91025F00013 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91025F00013 competed?
The extent of competition for 75N91025F00013 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award